No Data
No Data
Oncolytics Biotech Is Maintained at Buy by Maxim Group
Oncolytics Biotech Price Target Cut to $3.00/Share From $5.00 by Maxim Group
VerifyMe Price Target Lowered to $2 From $3 at Maxim
Maxim Group Initiates Coverage On Healthy Choice Wellness With Buy Rating, Announces Price Target of $2
Maxim Group Remains a Buy on Nephros (NEPH)
Maxim Starts Healthy Choice Wellness at Buy on Rising Organic Grocery Footprint
Unlock the Full List